Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06867900
NA
Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View on ClinicalTrials.gov
Summary
Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
22
Start Date
2021-01-01
Completion Date
2025-07-06
Last Updated
2025-03-10
Healthy Volunteers
Yes
Conditions
Interventions
DIETARY_SUPPLEMENT
Bifidobacterium Longum ES1
Oral administration of Bifidobacterium Longum ES1 for three months.
Locations (1)
Reasearch Laboratory 3J IRCCS Gemelli
Rome, Italy